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Ultraviolet B radiation can suppress cellular immun-
ity. One of the mechanisms related to this immuno-
suppression is the disappearance of Langerhans cells
from the epidermis. The aim of this study was to
establish the mechanism of ultraviolet B-induced
Langerhans cell disappearance in healthy individuals.
The two most likely mechanisms for Langerhans cell
disappearance are apoptosis and migration.
Apoptosis was assessed in vivo by exposing buttock
skin of 10 healthy volunteers to six minimal
erythema doses of ultraviolet B. Only very few apop-
totic Langerhans cells could be observed in sections
from the ultraviolet B-exposed skin. Migration of
Langerhans cells cannot be established in skin sec-
tions and suction blisters were therefore raised in an
attempt to trap migrating Langerhans cells in the
sub-basal membrane blister ¯uid. Blisters were raised
on the ¯exor side of the lower arm of 30 healthy vol-
unteers at several time points after exposure of the
skin to six minimal erythema doses of ultraviolet B.
Blister ¯uid was collected and blister roofs were
removed to check for Langerhans cell disappearance.
Langerhans cells were detected in the blister ¯uid of
the ultraviolet B-exposed skin and not of the unex-
posed skin. The number of Langerhans cells in the
blister ¯uid peaked at about 18 h after ultraviolet
exposure, which coincided with the largest depletion
of Langerhans cells in the blister roof. A fraction
(20±30%) of the Langerhans cells in the blister ¯uid
stained positive for DNA damage (cyclobutyl pyri-
midine dimers), showing that they originated from
the epidermis. Ultraviolet B-induced Langerhans cell
disappearance appears to be mainly attributable to
migration. Key words: caspase/pyrimidine dimers/suction
blister/ultraviolet immunosuppression. J Invest Dermatol
118:812±817, 2002
U
ltraviolet (UV) radiation, especially UVB radiation
(280±315 nm) has several effects on the skin
immune system. There are several primary photo-
chemical reactions that could trigger these events.
The most studied are: isomerization of urocanic acid
and DNA damage (cyclobutyl pyrimidine dimers and 6±4
photoproducts) in epidermal cells. Subsequently, the production
of cytokines is induced, such as interleukin-1b, tumor necrosis
factor-a, interleukin-10, and prostaglandin E2. Cellular functions
are altered, e.g., natural killer cell activity is inhibited, antigen
presentation is changed, and the microenvironment becomes
favorable to the development of T-helper 2-like immune responses
(for review Duthie et al, 1999). (Over)exposure of the skin to UVB
leads to an in¯ux of interleukin-10 producing macrophagic cells
(Kang et al, 1994, 1998) and a depletion of Langerhans cells. These
effects are associated with suppression of cellular immune reactions.
A disturbance in these immunosuppressive mechanisms may
lead to the development of a UV-induced ``sun allergy''
(polymorphous light eruption). Patients with polymorphous light
eruption are sensitive to UVB (as clinically tested by challenges
with a Philips TL12 lamp), UVA, and sometimes even to
visible light. These patients develop papules, vesicles, or eczema
on sun-exposed areas of the skin (Epstein, 1997; Grabczyska
and Hawk, 1997; Salomon et al, 1997; Boonstra et al, 2000).
Polymorphous light eruption is suggested to be a delayed-type
hypersensitivity reaction (Epstein, 1997; Norris et al, 1988;
Verheyen et al, 1995). In earlier experiments we found that
Langerhans cells in the skin of polymorphous light eruption
patients persisted after overexposure to UVB in contrast to what
was observed in healthy volunteers (KoÈlgen et al, 1999). We
hypothesize that this persistence of Langerhans cells in the
epidermis may contribute to the pathogenesis of the disease. To
understand this defect in polymorphous light eruption patients,
the main mechanism that is responsible for the UV-induced
Langerhans cell disappearance in healthy individuals needs to be
established.
The paramount mechanism underlying Langerhans cell deple-
tion, especially in humans, is still unknown. Some authors suggest
that a de®ciency of growth factors for Langerhans cells or a
downregulation of growth factor receptors is responsible for
Langerhans cell depletion (Takashima, 1995). The best studied
and two most likely mechanisms for epidermal Langerhans cell
depletion are apoptosis and/or migration.
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In vitro experiments revealed that irradiated human Langerhans
cells undergo apoptosis (Rattis et al, 1998). Experiments with mice
showed that apoptosis of Langerhans cells is induced by UVB
radiation through, among others, the production of reactive
oxygen species (Takashima, 1995). Whether this also occurs in
humans in vivo has still not been demonstrated (Meunier, 1999).
We know from animal models that Langerhans cells migrate to
the lymph nodes after exposure of the skin to UVB (Sontag et al,
1995; Dandie et al, 1998). UV-induced migration of Langerhans
cells in humans has been described by Yawalkar et al, 1998). These
last experiments (performed by Yawalkar), however, involve lymph
drainage, and are very encumbering and dif®cult to perform;
moreover, they were not approved of by the ethical committee of
our institute. We therefore had to resort to a novel technique.
To investigate the relative importance of apoptosis vs migration in
UV-induced Langerhans cell depletion in vivo we studied a group of
healthy volunteers. A small area of the buttock skin or ¯exor side of
the arm was overexposed to UVB. Biopsies were taken from buttock
skin at successive time points after exposure. Furthermore, we
developed a novel method to detect migrating Langerhans cells
in vivo by catching them in blister ¯uid: suction blisters were raised
on (un)exposed areas of the skin of the ¯exor lower arm, and blister
roofs and blister ¯uid were collected at several time points after UVB
exposure. Immunohistochemical stainings for CD1a (Langerhans
cells), cyclobutyl pyrimidine dimers (DNA damage), and for active
caspase 3 and terminal deoxynucleotidyl transferase (TdT)-mediated
deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL)
(both markers for apoptosis) were performed on frozen skin sections,
blister roofs, and cytospins of blister ¯uid.
MATERIALS AND METHODS
Subjects Thirty healthy individuals (nine males and 21 females, aged
between 19 and 55 y) were studied for Langerhans cell migration (see
below), whereas 10 healthy individuals (three males and seven females,
aged between 22 and 31 y) were studied for apoptosis. Volunteers whose
buttock skin or skin of the lower arm was exposed to sunlight less than
2 mo ago were excluded. Informed consent was obtained from all
volunteers. This study was approved by the Medical Ethical Committee
of the University Medical Center, Utrecht, the Netherlands.
Phototesting procedure The UV dose required to cause a just
perceptible redness, the minimal erythema dose (MED), was determined
on the skin area to be experimented on, i.e., the buttock skin or ¯exor
side of the lower arm. For MED determination a test device with nine
windows (3 3 10 mm each) was used. Through these windows the
underlying skin was exposed to a Philips TL12 lamp for different periods
of time (a geometrical series, e.g., from 12.4 to 200 s). The TL12 lamp
emitted 58% of the UV output in UVB (280±315 nm) and 5% of the
UV output below 290 nm. Erythemally weighted, 98% stemmed from
the UVB band (18% below 290 nm). The erythema was assessed 24 h
later. The MED for the buttock skin ranged from 212 to 750 J per m2
UVB (median of 410 J per m2, 95% CI 180±940 J per m2). The MED
for the ¯exor side of the arm was four to ®ve times higher and ranged
from 352 to 4840 J per m2 UVB (median of 1650 J per m2, 95% CI
470±5820 J per m2). After determination of the MED the test areas of
skin on the buttock or lower arm were exposed to 6 MED UV (Philips
TL12). According to Barr et al (1999) this dose is about equal to 4 MED
for an erythema de®ned by clear borders, as used by Cooper et al (1992)
to suppress contact hypersensitivity in humans.
Biopsies Three millimeter punch biopsies were taken from the
irradiated buttock skin 24 h and 48 h after exposure to 6 MED UV,
together with one control biopsy from the unexposed buttock skin.
Biopsies were snap frozen in liquid nitrogen, embedded in OCT
compound (Tissue-Tek, Sakura, Zoeterwoude, the Netherlands) and
stored at ±30°C until further processing.
Suction blisters Suction blisters were raised (van der Leun et al, 1974;
Black et al, 1977) for operational convenience on the irradiated skin of
the ¯exor side of the lower arm at several time points after exposure to
6 MED UV (18 h, 24 h, 30 h, 42 h, 48 h) and on an unexposed side
(two blisters per volunteer). Blisters were raised over a period of about
2 h, using airtight cups with circular ports exposing skin areas of 10 mm
in diameter to an atmospheric pressure of ±200 mmHg. Suction blister
formation was further stimulated by gently warming the skin via an
electric heating coil in each suction cup. Skin temperature was measured
with a copper-constantan thermocouple touching the skin, and did not
exceed 40°C. Blisters occurred at a dermal±epidermal junction. Blister
¯uid was collected using a microneedle with a diameter of 0.36 mm.
Blister roofs were removed with a sterilized skin surgery set. Each
volunteer was sampled at only one time point after irradiation. The yield
of blister ¯uid varied among individuals, but slightly more blister ¯uid
was consistently recovered from UV-irradiated blisters when compared
with controls, as found earlier by Barr et al (1999). Cytospin preparations
were made of the blister ¯uid by centrifugation for 10 min at 55 3 g on
to 3-amino-propyltriethoxysilane-coated glass slides. The slides were
stored at ±30°C until further processing. The removed blister roofs were
used immediately for immunohistochemistry.
Antibodies As primary antibodies, monoclonal antibodies CD1a
(DAKO A/S, Glostrup, Denmark, diluted 1:60), ¯uorescein
isothiocyanate (FITC)-conjugated CD1a (DAKO A/S, diluted 1:60) and
biotinylated H3 antibody (directed against cyclobutyl pyrimidine dimers,
a kind gift from Dr L. Roza; T.N.O., Zeist, the Netherlands; diluted
1:20), and the polyclonal antibody rabbit anti-active caspase 3 (Becton
Dickinson, San Diego, CA, diluted 1:100) were used. Biotinylated horse
anti-mouse immunoglobulin (Vector, Burlingame, CA; diluted 1:800)
and biotinylated goat anti-rabbit antibody (Vector; diluted 1:300) were
used as secondary antibodies. Alkaline phosphatase (AP)-labeled F(ab)
fragments of sheep anti-FITC (Boehringer Mannheim GmbH,
Mannheim, Germany; diluted 1:400), AP-labeled avidin±biotin complex
(DAKO A/S; diluted 1:50) horseradish peroxidase (HRP)-conjugated
avidin±biotin complex (DAKO A/S; diluted 1:50) were used as
detecting reagents.
Immunohistochemistry
Single staining of CD1a and anti-active caspase 3 Blister roofs and frozen
skin sections (6 mm) on 3-amino-propyltriethoxysilane-coated glass slides
were ®xed for 10 min at room temperature in dry acetone containing
100 ml 30% H2O2 per 100 ml. The slides were incubated for 20 min
with a blocking reagent [phosphate-buffered saline (PBS) containing 10%
normal human serum/10% normal horse serum or 10% normal goat
serum (depending on the secondary antibody species)] to prevent
Figure 1. Double staining of CD1a (blue) and active-caspase 3 (red) of buttock skin, unexposed (± UV), 24 h (+ UV + 24 h) and 48 h
after UVB exposure (+ UV + 48 h). Scale bar: 50 mm.
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aspeci®c binding. The skin sections were subsequently incubated with
the primary antibody (CD1a or rabbit-anti active caspase 3) for 1 h
and with a secondary antibody (biotinylated horse anti-mouse immuno-
globulin or biotinylated goat anti-rabbit immunoglobulin, respectively)
for 1 h. Subsequently, the blister roofs and skin sections were incubated
for 30 min with HRP-labeled avidin±biotin complex (CD1a) or AP-
labeled avidin±biotin complex (active caspase 3). Peroxidase activity was
visualized by incubation in 0.1 M acetate buffer (pH = 5) containing
20 mg 3-amino-9-ethyl-carbazole (AEC; Sigma, St Louis, MO) and
100 ml H2O2 per 100 ml, resulting in a red staining. Rabbit anti-active
caspase 3 binding was visualized by incubating the sections in Tris±HCl
(pH = 8.5) containing 25 mg levamisole, 250 ml New Fuchsin, 250 ml
0.6 M sodium nitrate solution and 50 mg naphthol AS-BI phosphate,
resulting in a pink staining.
Double staining of CD1a-FITC and H3-biotin CD1a-FITC/H3 double
staining was performed as described previously (Sontag et al, 1995)
without modi®cations. In short, blister roofs, cytospins of blister ¯uid,
and frozen skin sections were ®xed, preincubated with blocking reagent
(PBS containing 10% normal human serum) and incubated with the
primary antibody CD1a-FITC, as described above. After incubation for
1 h with AP-labeled sheep anti-FITC F(ab) the AP activity was
visualized by incubation in a BCIP/NBT solution of 5-bromo-4-chloro-
3-indolyl phosphate/4-nitro blue tetrazolium chloride in 0.1 M Tris±
HCl (pH = 9.5), 0.1 M NaCl, 0.05 M MgCl2, and 2.5 mg levamisole
per 10 ml. The bluish-black reaction product is water and ethanol
insoluble and withstands the subsequent harsh treatment. The
preparations were ®xed in 25% acetic acid (vol/vol) containing 100 ml
30% H2O2 per 100 ml. After washing two times for 10 min in PBS the
slides were incubated for exactly 2 min in 0.07 M NaOH in 70%
ethanol. After washing with PBS the preparations were incubated for
20 min with PBS containing 10% normal human serum and 10% normal
mouse serum, followed by a 1 h incubation with H3-biotin.The
preparations were incubated with HRP-labeled avidin±biotin complex
for 30 min and developed in an AEC substrate solution, as described
above.
Double staining of CD1a-FITC and anti-active caspase 3 CD1a-FITC/active
caspase 3 double staining was performed on blister roofs and frozen skin
sections. Fixation and preincubation of the skin sections was performed
as described above. The sections were then incubated simultaneously
with CD1a-FITC and anti-active caspase 3 antibody for 1 h. The
preparations were subsequently incubated simultaneously with
biotinylated goat-anti-rabbit and AP-labeled sheep anti-FITC for 1 h,
followed by incubation for 30 min with HRP-labeled avidin±biotin
complex. AP activity was visualized by incubating the sections ®rst in a
Tris±HCl buffer (pH = 8.5), containing 25 mg Fast Blue BB Salt,
12.5 mg naphthol AS-MX phosphate, and 35 mg levamisole per 100 ml
(all purchased from Sigma), resulting in a blue staining. For visualization
of the peroxidase activity the sections were then incubated with an AEC
solution, as described above. Negative staining controls were used in
single and double staining experiments in which the ®rst antibody was
omitted or replaced by an irrelevant antibody of the same isotype. All
antibodies were diluted in the suitable blocking reagent except for the
AP- and HRP-labeled antibodies, which were diluted in PBS/0.05%
Tween 20. All antibody incubations were performed in a humidi®ed
chamber at room temperature. After each antibody incubation the slides
were washed three times with PBS containing 0.05% Tween 20.
TUNEL To detect DNA breaks in situ, TUNEL staining was
performed using a commercially available detection kit (Boehringer
Mannheim GmbH). Frozen skin sections (6 mm) on 3-amino-
propyltriethoxysilane-coated glass slides were stained according to
manufacturer's instruction. Incorporation of FITC labeled nucleotides
was checked using a Zeiss microscope equipped for epi¯uorescence.
Converter-AP (anti-FITC antibody supplied in the kit) was then added
and antibody binding was visualized by incubation in a Fast Blue BB Salt
substrate solution, as described above. To detect whether the apoptotic
cells were Langerhans cells the TUNEL assay was combined with a
CD1a staining. CD1a antibody was incubated simultaneously with the
TdT reaction mixture. The sections were then incubated simultaneously
with biotinylated horse anti-mouse immunoglobulin and converter-AP
followed by incubation with HRP-labeled avidin±biotin complex.
Antibody binding was visualized by incubation with Fast Blue BB Salt
substrate solution (TUNEL) and AEC solution (CD1a), as described
above.
Statistical analysis After logarithmic transformation (to correct for the
right skewed distribution) a Student's t test was performed to ascertain
the signi®cance of the observed differences (signi®cance level p < 0.05).
The numbers of CD1a single positive and CD1a/H3 double positive
cells in the blister ¯uid after UV exposure were compared with the
numbers of unexposed, control skin.
RESULTS
Exposure to 6 MED causes apoptosis in the epidermis, but
not Langerhans cells Caspase 3 is an effector caspase that is
cleaved during apoptosis in a wide variety of cells and commits a
cell to apoptosis (for review see Harvey and Kumar, 1998;
Thornberry and Lazebnik, 1998).
Active caspase 3-positive cells are present in the epidermis 24 h
and 48 h after UVB irradiation and are abundantly present in blister
roofs within 18 h after 6 MED UVB irradiation. The number of
caspase 3-positive cells 24 h after UVB exposure varies greatly
among volunteers. Active caspase 3-positive cells are found
scattered throughout the epidermis 24 h after irradiation, whereas
after 48 h the cells are mainly located in the upper part of the
epidermis just below the stratum corneum (Fig 1). These apoptotic
cells are mainly found in conjunction with epidermal defects.
Active caspase 3-positive cells were not found in unirradiated skin.
Similar results were obtained with the TUNEL staining, but the
TUNEL assay had a higher background staining (data not shown).
To test whether the caspase 3-positive cells found in the UVB-
irradiated skin were Langerhans cells, a double staining was
performed with the dendritic cell marker CD1a. No double
positive cells could be detected in the UVB-irradiated skin (Fig 1).
The Langerhans cells tended to be low in the epidermis or in the
dermis, whereas the apoptotic cells were higher up in the
epidermis. A few (< 1% of the total number of Langerhans cells
from unirradiated skin and < 3% of the total number of Langerhans
cells from UVB-exposed skin) caspase 3-positive or TUNEL-
positive Langerhans cells could occasionally be observed in the
blister roofs of the UVB-irradiated skin.
CD1a+ Langerhans cells can be detected in the blister ¯uid
of the UVB-exposed skin, but not of the unexposed
skin To test whether UVB-induced Langerhans cell depletion
was caused by migration, suction blisters were raised on UVB-
irradiated skin and unirradiated skin. Blister roofs and blister ¯uid
were sampled at several time points after irradiation. CD1a staining
of blister roofs showed a signi®cant decline (p < 0.0001) in the
number of Langerhans cells after UVB irradiation (median of 259
cells per mm2, 95% CI 146±462 cells per mm2) when compared
with the unirradiated control (median of 720 cells per mm2, 95%
CI 520±996 cells per mm2) (Fig 2). The largest decrease appeared
Figure 2. Number of CD1a+ Langerhans cells (mean 6 SEM) in
blister roofs (bullet) and blister ¯uid (CD1a+ cells, j and
CD1a+/H3+ cells, m, of arm skin, unexposed (0 h) and UVB-
exposed (18 h, 24 h, 30 h, 42 h, 48 h). Average n per time-
point = 5.
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to occur over the ®rst 18 h period (60%), whereas between 18 h
and 48 h there was a further decrease of only 10%.
Blister ¯uid was sampled to collect migrating Langerhans cells.
Very few other cells were detected in the ¯uid (except for a minor
admixture of about 50 cells in three of 30 cases in which blisters
developed more quickly within about 1.5 h). CD1a staining
performed on cytospin preparations of blister ¯uid showed a
signi®cant difference (p < 0.0001) between UVB-irradiated and
unirradiated skin. CD1a+ Langerhans cells could be detected in the
blister ¯uid of the UVB-exposed skin, but not in the blister ¯uid of
the unirradiated skin. The number of CD1a+ cells varied strongly
among the healthy individuals (median of 115 cells per 100 ml
sample, 95% CI 17±796 cells per 100 ml sample) (Fig 2). The
blister ¯uid from the earliest time point (18 h) showed the largest
number of Langerhans cells (median of 268 cells per 100 ml sample,
95% CI 44±1623 cells per 100 ml sample); however, the number of
Langerhans cells that were found in the blister ¯uid of an individual
did not correlate with the number of Langerhans cells that
disappeared from the blister roofs of the UVB-exposed skin
(rho = ± 0.355, p = 0.089, Spearman rank order correlation test).
The individual UVB doses (in J per m2) showed a negative
correlation with the numbers of Langerhans cells in the blister ¯uid
(rho = ± 0.421, p = 0.04, Spearman rank order correlation test),
whereas the UVB doses showed a positive correlation with the
decrease of Langerhans cells in the blister roofs (rho = 0.565,
p = 0.001, Spearman rank order correlation test). The maximum
number of Langerhans cells in the blister ¯uid at 18 h coincided
with the largest decrease in Langerhans cells in the blister roof.
Cyclobutyl thymidine dimers are detectable 18 h after
6 MED UVB in epidermal cells but only in a fraction of
the migrating Langerhans cells Skin biopsies, blister roofs, and
blister ¯uid were stained with H3 to detect UV-induced DNA
damage, containing thymidine dimers. After a single dose of
6 MED UVB most cells in blister roofs and skin biopsies are H3+.
Blister roofs or skin biopsies from unexposed skin did not contain
H3+ cells (Fig 3). H3 staining was performed on cytospin
preparations of blister ¯uid to con®rm that the CD1a+ cells
originated from the UV-exposed epidermis. CD1a/H3 double
positive cells could be observed in the blister ¯uid at different time
points (18 h±48 h) after UV irradiation (Fig 4). But only a
minority of the CD1a+ cells was H3+ (mean of 27%). The
percentage CD1a/H3 double positive cells of the total amount of
CD1a+ cells in the blister ¯uid was least at 42 h (15.3%) and
greatest at 24 h (38.8%) (Fig 2). Because of layering of cells and
excessive H3 staining it was dif®cult to interpret the CD1a/H3
staining in skin sections and whole blister roofs. Therefore, single
cell suspensions of blister roofs were double stained for CD1a and
H3 to check whether Langerhans cells in the UV-exposed skin also
contained UV-damaged DNA (Fig 3). The majority of the CD1a+
cells in single cell suspensions of blister roofs were H3+.
DISCUSSION
It is well known that UVB can induce immunosuppression in the
skin. One of the important processes associated with immunosup-
pression is the disappearance of the primary antigen-presenting cells
of the skin, the Langerhans cells. Here we investigated whether
apoptosis or migration dominated this prominent effect on the
epidermal antigen-presenting cells. The disruption of Langerhans
cell function can be fundamental to UV-induced immunosuppres-
sion either by incorrect, inappropriate, or inef®cient antigen
presentation (Duthie et al, 1999). Alternatively, depletion of
Langerhans cells could lead to modi®ed antigen presentation by
another cell type, e.g., in®ltrating monocytoid cells (Meunier et al,
1995).
In this study we ®rst focused on the role of apoptosis in UVB-
induced Langerhans cell depletion, as the occurrence of this
phenomenon in humans in vivo still has not convincingly been
demonstrated (Meunier, 1999). We show that only a few epidermal
CD1a+ Langerhans cells in skin biopsies or blister roofs undergo
apoptosis after UVB exposure, as detected by active-caspase 3 or
TUNEL. These results are in line with experiments of Okamoto et
al (1999), who showed in mice that after UV radiation only 1.5 cell
per 900 Langerhans cells per mm2 were apoptotic, which was far
too few to contribute substantially to the observed Langerhans cell
depletion. Hollis and Scheibner (1988) found that Langerhans cells
in UV-irradiated skin of Aboriginals were apoptotic. The evidence
is, however, circumstantial as the number of apoptotic Langerhans
cells was very low and the time frame used was not optimal (2 h or
5 d). In vitro experiments demonstrated that Langerhans cells did go
into apoptosis after UVB irradiation and 2 d of culture (Rattis et al,
1998). Tang and Udey (1992a) found that death of cultured murine
Figure 3. Double staining of CD1a (blue) and
H3 (red) of buttock skin, unexposed (± UV)
and 24 h after UVB exposure (+ UV) with an
example of a doubled stained cell, migrating
out of the epidermis (black arrow). Scale
bar: 50 mm.
Figure 4. Double staining of CD1a (blue) and H3 (red) in blister
¯uid of the UVB-exposed skin.
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Langerhans cells is augmented by UVB irradiation. A population of
HLA-DR+ cells migrating from cultured, ex vivo irradiated skin
explants are shown to be apoptotic (Nakagawa et al, 1999).
Mommaas et al (1993) showed by electron microscopy that some
human Langerhans cells become necrotic when irradiated with
UVB in vitro; however, necrotic cells also become TUNEL+, but
were not detected as Langerhans cells in our study. Furthermore,
lack of swollen, disintegrated Langerhans cells (detected by CD1a,
Lag, or HLA-DR; data not shown) indicates that necrosis is
negligible for UV-induced Langerhans cell depletion.
A possible explanation for the difference in UV-induced death of
Langerhans cells between the in vitro or ex vivo and the in vivo
situation could be the difference in environment. In human skin,
which consists of several layers of epidermal cells, Langerhans cells
might be protected by the surrounding cells. This might be due to
protective shielding, but also by cell±cell contacts, cell surface
molecules, and cytokines that are lacking or different in vitro (Tang
and Udey, 1992b; Laihia and Jansen, 2000). One could argue that
the CD1a marker may be lost during apoptosis and that this is the
reason why we could hardly detect any apoptotic CD1a+ cells.
Nakagawa et al (1999) showed in their in vitro experiments,
however, that annexin V+ apoptotic cells from UVB-irradiated skin
exhibited a high expression of CD1a, which would imply that
apoptotic Langerhans cells retain their CD1a surface marker. Taken
together, our data show that apoptosis occurs abundantly in human
epidermis after overexposure to UVB; however, Langerhans cells
apparently do not go into apoptosis and this mechanism can
therefore not explain the UVB-induced depletion of Langerhans
cells in the epidermis.
The next step in unraveling the mechanism of UVB-induced
Langerhans cell depletion was investigating Langerhans cell migra-
tion. Pilot experiments had shown that it is feasible to catch
migrating Langerhans cells in vivo in the ¯uid of suction blisters.
Using this method we were indeed able to detect Langerhans cells
with pyrimidine dimers reproducibly in the blister ¯uid of the
UVB-exposed skin, and not in the blister ¯uid of the unexposed
skin. Blocking the emission of the Philips TL12 lamps below
290 nm (using a WG305/3 and a WG295/1 ®lter simultaneously)
to simulate a solar-simulating irradiation source resulted in an equal
number of Langerhans cells in the in blister roofs and blister ¯uid of
the UV-exposed skin as compared with the un®ltered TL12 lamps
(tested on two people, data not shown). The decrease in
Langerhans cell number in the blister roof after UVB radiation
did not correlate with the number of Langerhans cells found in the
blister ¯uid of the UVB-exposed skin, although the largest decrease
in the blister roof coincided with the largest increase in Langerhans
cell number in the blister ¯uid. The correlation is, however, likely
to be affected by factors such as variations between individuals in
time over which blisters were raised, differences in adherence of
Langerhans cells to the dermal blister ¯oor, amount of blister ¯uid,
and blister cross-section.
The presence of cyclobutyl pyrimidine dimers in the CD1a+ cells
in the blister ¯uid con®rmed that the cells originated from the
UVB-exposed epidermis. Overall 27% of Langerhans cells in the
blister ¯uid, but most of the epidermal cells (mainly keratinocytes),
had detectable levels of pyrimidine dimers. One could think of
several explanations for this low percentage of Langerhans cells
with detectable pyrimidine dimers. First of all, one could speculate
that the CD1a single positive cells do not originate from the
epidermis but are new dendritic cells coming from the blood stream
or hair follicles (Gilliam et al, 1998), or entering the blister ¯uid as a
result of the suction blister technique. It is, however, unlikely that
the undamaged Langerhans cells come from the dermis as their
dominant occurrence in blister ¯uid does not coincide with a
repopulation of the epidermis (KoÈlgen et al, 1999). Furthermore, it
does not appear to be an artifact of the method used, no in¯ux of
Langerhans cells could be observed in the blister ¯uid of the
unexposed skin. Moreover, cytokeratin 14 staining on basal
keratinocytes in the blister roof of the UVB-irradiated skin showed
that the integrity of the blister roof was not affected by the method
used nor by UVB irradiation (data not shown). Hence, Langerhans
cells are not likely to be released from the epidermis through defects
caused by the blister formation. Alternatively, it could be that the
Langerhans cells had a low initial damage level (Vink et al, 1994) or
a rapid DNA repair. The undamaged Langerhans cells may show
selective responsiveness to migratory signals, such as tumor necrosis
factor-a. By staining single cell suspensions of blister roofs (18 h
time point) it was indeed possible to see a clear enrichment of
DNA-damaged Langerhans cells (approximately 80±90%) in blister
roofs compared with blister ¯uid. Of note is the difference in
percentage of double positive cells between 18 h (20.1% of
Langerhans cells) and 24 h (38.8% of Langerhans cells). These
percentages are mainly in¯uenced by the number of CD1a single
positive cells because the absolute number of damaged Langerhans
cells in the blister ¯uid is almost the same between 18 h and 30 h.
This also suggests that undamaged Langerhans cells are quicker to
migrate.
In this study, it has been shown that raising suction blisters is an
easy-to-use method to catch migrating Langerhans cells in human
beings in vivo. These data show that UVB-induced Langerhans cell
depletion in human skin is mainly caused by migration and not by
apoptosis.
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